288 related articles for article (PubMed ID: 31330829)
1. The IL4I1 Enzyme: A New Player in the Immunosuppressive Tumor Microenvironment.
Molinier-Frenkel V; Prévost-Blondel A; Castellano F
Cells; 2019 Jul; 8(7):. PubMed ID: 31330829
[TBL] [Abstract][Full Text] [Related]
2. An Overview of l-Amino Acid Oxidase Functions from Bacteria to Mammals: Focus on the Immunoregulatory Phenylalanine Oxidase IL4I1.
Castellano F; Molinier-Frenkel V
Molecules; 2017 Dec; 22(12):. PubMed ID: 29206151
[TBL] [Abstract][Full Text] [Related]
3. IL4-induced gene 1 is secreted at the immune synapse and modulates TCR activation independently of its enzymatic activity.
Aubatin A; Sako N; Decrouy X; Donnadieu E; Molinier-Frenkel V; Castellano F
Eur J Immunol; 2018 Jan; 48(1):106-119. PubMed ID: 28891065
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 4-Induced Gene 1 as an Emerging Regulator of B-Cell Biology and its Role in Cutaneous Melanoma.
Prevost-Blondel A; Richard Y
Crit Rev Immunol; 2019; 39(1):39-57. PubMed ID: 31679193
[TBL] [Abstract][Full Text] [Related]
5. Emerging Role of IL-4-Induced Gene 1 as a Prognostic Biomarker Affecting the Local T-Cell Response in Human Cutaneous Melanoma.
Ramspott JP; Bekkat F; Bod L; Favier M; Terris B; Salomon A; Djerroudi L; Zaenker KS; Richard Y; Molinier-Frenkel V; Castellano F; Avril MF; Prévost-Blondel A
J Invest Dermatol; 2018 Dec; 138(12):2625-2634. PubMed ID: 30048651
[TBL] [Abstract][Full Text] [Related]
6. The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophages.
Carbonnelle-Puscian A; Copie-Bergman C; Baia M; Martin-Garcia N; Allory Y; Haioun C; Crémades A; Abd-Alsamad I; Farcet JP; Gaulard P; Castellano F; Molinier-Frenkel V
Leukemia; 2009 May; 23(5):952-60. PubMed ID: 19436310
[TBL] [Abstract][Full Text] [Related]
7. What role for AHR activation in IL4I1-mediated immunosuppression ?
Castellano F; Prevost-Blondel A; Cohen JL; Molinier-Frenkel V
Oncoimmunology; 2021 May; 10(1):1924500. PubMed ID: 34026337
[TBL] [Abstract][Full Text] [Related]
8. IL4I1: Key immunoregulator at a crossroads of divergent T-cell functions.
Romagnani S
Eur J Immunol; 2016 Oct; 46(10):2302-2305. PubMed ID: 27726138
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-4 induced 1-mediated resistance to an immune checkpoint inhibitor through suppression of CD8
Hirose S; Mashima T; Yuan X; Yamashita M; Kitano S; Torii S; Migita T; Seimiya H
Cancer Sci; 2024 Mar; 115(3):791-803. PubMed ID: 38258342
[TBL] [Abstract][Full Text] [Related]
10. Alterations of the immunosuppressive IL4I1 enzyme activity induced by naturally occurring SNP/mutations.
Molinier-Frenkel V; Mestivier D; Castellano F
Genes Immun; 2016 Mar; 17(2):148-52. PubMed ID: 26673964
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial properties of the mammalian L-amino acid oxidase IL4I1.
Puiffe ML; Lachaise I; Molinier-Frenkel V; Castellano F
PLoS One; 2013; 8(1):e54589. PubMed ID: 23355881
[TBL] [Abstract][Full Text] [Related]
12. Human IL4I1 is a secreted L-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation.
Boulland ML; Marquet J; Molinier-Frenkel V; Möller P; Guiter C; Lasoudris F; Copie-Bergman C; Baia M; Gaulard P; Leroy K; Castellano F
Blood; 2007 Jul; 110(1):220-7. PubMed ID: 17356132
[TBL] [Abstract][Full Text] [Related]
13. [The role of IL4I1 in immunoregulation: An update].
Liu W; Dong C; Liu X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jan; 37(1):79-83. PubMed ID: 33441232
[TBL] [Abstract][Full Text] [Related]
14. The immunosuppressive enzyme IL4I1 promotes FoxP3(+) regulatory T lymphocyte differentiation.
Cousin C; Aubatin A; Le Gouvello S; Apetoh L; Castellano F; Molinier-Frenkel V
Eur J Immunol; 2015 Jun; 45(6):1772-82. PubMed ID: 25778793
[TBL] [Abstract][Full Text] [Related]
15. IL4I1: an inhibitor of the CD8⁺ antitumor T-cell response in vivo.
Lasoudris F; Cousin C; Prevost-Blondel A; Martin-Garcia N; Abd-Alsamad I; Ortonne N; Farcet JP; Castellano F; Molinier-Frenkel V
Eur J Immunol; 2011 Jun; 41(6):1629-38. PubMed ID: 21469114
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of IL4-induced gene 1 enzyme by B2 cells during melanoma progression impairs their antitumor properties.
Bekkat F; Seradj M; Lengagne R; Fiore F; Kato M; Lucas B; Castellano F; Molinier-Frenkel V; Richard Y; Prévost-Blondel A
Eur J Immunol; 2024 Apr; 54(4):e2350615. PubMed ID: 38400692
[TBL] [Abstract][Full Text] [Related]
17. IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression.
Sadik A; Somarribas Patterson LF; Öztürk S; Mohapatra SR; Panitz V; Secker PF; Pfänder P; Loth S; Salem H; Prentzell MT; Berdel B; Iskar M; Faessler E; Reuter F; Kirst I; Kalter V; Foerster KI; Jäger E; Guevara CR; Sobeh M; Hielscher T; Poschet G; Reinhardt A; Hassel JC; Zapatka M; Hahn U; von Deimling A; Hopf C; Schlichting R; Escher BI; Burhenne J; Haefeli WE; Ishaque N; Böhme A; Schäuble S; Thedieck K; Trump S; Seiffert M; Opitz CA
Cell; 2020 Sep; 182(5):1252-1270.e34. PubMed ID: 32818467
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of the immunosuppressive enzyme IL4I1 in human induced Aiolos+, but not natural Helios+, FOXP3+ Treg cells.
Scarlata CM; Celse C; Pignon P; Ayyoub M; Valmori D
Eur J Immunol; 2015 Feb; 45(2):474-9. PubMed ID: 25446972
[TBL] [Abstract][Full Text] [Related]
19. Pan-cancer analysis combined with experimental validation revealed IL4I1 as an immunological and prognostic biomarker.
Rao D; Yu C; Wang T; Sheng J; Lv E; Liang H; Huang W; Dong H
Int Immunopharmacol; 2022 Oct; 111():109091. PubMed ID: 35952516
[TBL] [Abstract][Full Text] [Related]
20. IL4-induced gene 1 promotes tumor growth by shaping the immune microenvironment in melanoma.
Bod L; Lengagne R; Wrobel L; Ramspott JP; Kato M; Avril MF; Castellano F; Molinier-Frenkel V; Prévost-Blondel A
Oncoimmunology; 2017; 6(3):e1278331. PubMed ID: 28405502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
